You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

Profile for Serbia Patent: 54054


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Serbia Patent: 54054

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
RE46965 Jul 8, 2027 Eisai Inc HALAVEN eribulin mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Serbia Patent RS54054

Last updated: July 31, 2025

Introduction

Patent RS54054 pertains to a pharmaceutical invention registered in Serbia, providing a legal framework for its rights, scope, and claims. Analyzing this patent requires understanding its scope, core claims, and how it fits within the broader pharmaceutical patent landscape. This report offers a detailed examination tailored for business professionals, legal practitioners, and industry stakeholders seeking to assess the patent's strength, competitive implications, and innovation positioning.

Patent Overview

RS54054 was granted by the Serbian Intellectual Property Office (SIPO). While specific data on the patent's filing date, inventors, and assignee are not specified here, typical patent documents include fundamental details, such as the invention's title, abstract, and claims. For comprehensive analysis, the claims define the patent’s legal scope and are pivotal in determining infringement and validity.

Scope of Patent RS54054

Type and Category

The patent falls within the pharmaceutical segment, likely protecting a novel chemical compound, formulation, or method of use. Given Serbia's participation in global patent harmonization efforts, RS54054 must meet criteria of novelty, inventive step, and industrial applicability.

Allowed Scope

Based on standard pharmaceutical patent protections, RS54054's scope potentially covers:

  • Chemical Structure: Specific molecular entities or derivatives with therapeutic utility.
  • Formulation: Unique compositions, excipient combinations, or delivery systems.
  • Method of Use: Novel therapeutic applications or treatment protocols.
  • Manufacturing Process: Innovative synthesis or processing techniques.

The scope's breadth depends heavily on how the claims are drafted — broad claims cover more ground but may face higher invalidation risk; narrow claims offer targeted protection but risk design-around by competitors.

Territorial Limitations

The patent's protection is primarily enforceable within Serbia. However, given Serbia's alignment with regional and international treaties (such as the European Patent Convention), patent rights may serve as a basis for subsequent filings in other jurisdictions, or for regional enforcement strategies.

Claims Analysis

Claim Structure

Patent claims typically include an independent claim(s), which broadly define the invention, and dependent claims that specify particular embodiments or limitations.

Core Features of the Claims

Without the exact text, assumptions based on typical pharmaceutical patents suggest:

  • Chemical Composition Claims: Cover specific compounds, such as a novel active pharmaceutical ingredient (API).
  • Method Claims: Encompass a specific method of synthesizing the compound or administering it.
  • Use Claims: Protect novel therapeutic indications or dosages.
  • Formulation Claims: Detail specific formulations that improve stability, bioavailability, or patient compliance.

Strengths and Limitations

  • Strengths: Well-drafted independent claims that broadly cover the compound or method can prevent competitors from copying essential features.
  • Limitations: Narrow claims, or claims limited to specific forms, may be easier for competitors to bypass.

Claim Novelty and Inventive Step

The patent must demonstrate that the claimed invention is neither disclosed nor obvious based on prior art. This includes:

  • Prior Art Search: Extensive documentation, including previous patents, scientific literature, and public disclosures.
  • Distinctiveness: The claims must specify features that distinguish RS54054 from existing compounds or methods.

Patent Landscape and Competition

Global Patent Trends

Serbia’s pharmaceutical patent landscape aligns with European and international standards. Key points include:

  • Regional Patent Strategy: Companies often file in Serbia as part of regional strategies targeting the European single patent system.
  • Patent Families: The patent’s family members, if any, may extend protection to other jurisdictions, indicating the assignee's strategic intent.

Comparative Analysis

  • RS54054’s claims should be compared with similar patents in the Balkan region, Europe, and global markets to gauge competitive strength.
  • The patent's scope should be assessed against recent filings covering comparable compounds or therapeutic methods.

Potential Infringement and Litigation Risks

Given the patent’s claims, competitors might attempt to design around specific features, leading to potential infringement challenges. Conversely, patent holders might enforce rights against infringers or negotiate licensing agreements.

Legal and Commercial Implications

  • Market Exclusivity: The patent grants exclusive rights in Serbia, providing a window for commercialization without direct competition.
  • Research and Development (R&D): The patent’s scope influences ongoing R&D investments, guiding innovation pathways.
  • Regulatory Considerations: Patent protection can streamline regulatory approvals for novel formulations or uses, enhancing market entry prospects.

Conclusion

Patent RS54054's value hinges on its claims' breadth and enforceability. A well-drafted patent that encompasses broad chemical, method, and use claims offers significant competitive advantage. However, the actual scope must be validated against prior art and potential design-around strategies. Strategic patent management, including possible extensions or complementary patents, can bolster market position.


Key Takeaways

  • Scope Definition: RS54054 likely covers specific chemical entities and therapeutic methods, the breadth of which influences market exclusivity.
  • Claims Strategy: The strength and enforceability depend on the specificity and novelty of the claims; broader claims provide more protection but require strong inventive support.
  • Patent Landscape: The patent is a critical asset within Serbia, with regional implications that require monitoring of global patents to avoid infringement risks.
  • Legal Position: The patent’s enforceability can be bolstered by aligning claims with European patent standards and conducting ongoing patent landscape analyses.
  • Market Strategy: Securing and defending this patent position is vital for the commercialization of related pharmaceutical products in Serbia and beyond.

FAQs

1. What is the typical scope of pharmaceutical patents like RS54054?
Pharmaceutical patents generally cover novel chemical compounds, formulations, manufacturing processes, and therapeutic methods. The scope depends on claim drafting, balancing broad protection against the risk of invalidation.

2. How can I determine if RS54054’s claims are valid over prior art?
Conducting a thorough patent and scientific literature search helps identify prior disclosures. A patent examiner or patent attorney can evaluate inventive step, novelty, and claim validity based on existing prior art.

3. Can RS54054’s patent be extended or broadened?
In certain cases, amendments or supplementary protection certificates (SPCs) can extend patent protection; however, patent claims cannot typically be broadened after grant without new filings.

4. How does Serbia’s patent law influence the enforceability of RS54054?
Serbian patent law aligns with regional standards, offering a legal framework for enforcement through civil litigation, administrative actions, and potential customs measures against infringers.

5. What strategic considerations should companies have regarding patent RS54054?
Assessing patent strength and potential infringement risks, filing complementary patents, planning for regional extensions, and monitoring competitor filings are crucial for maximizing patent value.


References

  1. Serbian Intellectual Property Office (SIPO), Official Patent Database.
  2. European Patent Office, Patent Search Resources.
  3. World Intellectual Property Organization (WIPO), PATENTSCOPE Database.
  4. International Patent Classification (IPC), for pharmaceutical patents.
  5. Regulatory and legal frameworks applicable in Serbia, as per national and regional laws.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.